Increased GLI expression and activity has been associated with poor prognosis, development of high-grade tumors and resistance to chemotherapy in multiple malignancies (5, 6) including pancreatic ductal adenocarcinoma (PDAC; refs. 7–13). The gene discussed is GLI1; the disease is pancreatic ductal adenocarcinoma.